Search Results - Fesnak, A.D

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL)

    Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (R/R)... by Levine, B.L, Maude, S, Zheng, Z, Shaw, P, Ambrose, D, Aplenc, R, Barker, C, Barrett, D, Brogdon, J, Callahan, C, Chen, F, Chew, A, Suhoski Davis, M.M, Fesnak, A.D, Finklestein, J, Frey, N, Lacey, S, Lamontagne, A, Lewitt, L, Loew, A, Marcucci, K, Melenhorst, J, Motley, L, Mudambi, M, Nazimuddin, F, O'Rourke, M, Porter, D, Rheingold, S.R, Scholler, J, Tayor, C, White, C, Wood, P, Young, R, Teachey, D.T, June, C, Grupp, S

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    25 - Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL)

    25 - Durable Remissions with Control of Cytokine Release Syndrome (CRS) Using T Cells Expressing CD19 Targeted Chimeric Antigen Receptor (CAR) CTL019 to Treat Relapsed/Refractory (... by Levine, B.L., Maude, S., Zheng, Z., Shaw, P., Ambrose, D., Aplenc, R., Barker, C., Barrett, D., Brogdon, J., Callahan, C., Chen, F., Chew, A., Suhoski Davis, M.M., Fesnak, A.D., Finklestein, J., Frey, N., Lacey, S., Lamontagne, A., Lewitt, L., Loew, A., Marcucci, K., Melenhorst, J., Motley, L., Mudambi, M., Nazimuddin, F., O'Rourke, M., Porter, D., Rheingold, S.R., Scholler, J., Tayor, C., White, C., Wood, P., Young, R., Teachey, D.T., June, C., Grupp, S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: